MAPT and early-onset autosomal dominant Alzheimer disease: In some cohort studies about Alzheimer’s disease, the researchers observed that the level of CSF ferritin might accelerate the disease process (Ayton et al., 2017, 2018; Pan et al., 2022), and relate to phosphorylated tau, total tau, and inflammatory factors (Pan et al., 2022).